These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe. Dietrich JJ, Ahmed N, Webb EL, Tshabalala G, Hornschuh S, Mulaudzi M, Atujuna M, Stranix-Chibanda L, Nematadzira T, Ssemata AS, Muhumuza R, Seeley J, Bekker LG, Weiss HA, Martinson N, Fox J, CHAPS team. J Int AIDS Soc; 2022 Aug; 25(8):e25975. PubMed ID: 36002910 [Abstract] [Full Text] [Related]
4. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa. Dietrich JJ, Atujuna M, Tshabalala G, Hornschuh S, Mulaudzi M, Koh M, Ahmed N, Muhumuza R, Ssemata AS, Otwombe K, Bekker LG, Seeley J, Martinson NA, Terris-Prestholt F, Fox J. BMC Health Serv Res; 2021 Jan 06; 21(1):17. PubMed ID: 33407395 [Abstract] [Full Text] [Related]
6. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries. Kakande A, Ssemata AS, Muhumuza R, Atujuna M, Abaasa A, Ndekezi D, Tshabalala G, Nematadzira T, Hornschuh S, Nomvuyo M, Ahmed N, Maluadzi M, Anne Weiss H, Webb E, Stranix-Chibanda L, Janine Dietrich J, Seeley J, Fox J. PLoS One; 2023 Jan 06; 18(10):e0285132. PubMed ID: 37812644 [Abstract] [Full Text] [Related]
7. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa. Muhumuza R, Ssemata AS, Kakande A, Ahmed N, Atujuna M, Nomvuyo M, Bekker LG, Dietrich JJ, Tshabalala G, Hornschuh S, Maluadzi M, Chibanda-Stranix L, Nematadzira T, Weiss HA, Nash S, Fox J, Seeley J. Arch Sex Behav; 2021 May 06; 50(4):1729-1742. PubMed ID: 33954824 [Abstract] [Full Text] [Related]
8. "I prefer to take pills when I plan to have sex": Perceptions of on-demand versus daily oral pre-exposure prophylaxis among adolescents in Kampala, Uganda. Kawuma R, Nabalwanyi Z, Seeley J, Mayanja Y. Afr J AIDS Res; 2022 Mar 06; 21(1):8-14. PubMed ID: 35361065 [Abstract] [Full Text] [Related]
9. Baseline preferences for oral pre-exposure prophylaxis (PrEP) or dapivirine intravaginal ring for HIV prevention among adolescent girls and young women in South Africa, Uganda and Zimbabwe (MTN-034/IPM-045 study). Ngure K, Friedland BA, Szydlo DW, Roberts ST, Garcia M, Levy L, Akello CA, Reddy K, Palanee-Phillips T, Macdonald P, Siziba B, Soto-Torres L, Hosek S, Hillier SL, Nair G, Celum C, van der Straten A. PLoS One; 2023 Mar 06; 18(6):e0287525. PubMed ID: 37352296 [Abstract] [Full Text] [Related]
10. How a menu of adherence support strategies facilitated high adherence to HIV prevention products among adolescent girls and young women in sub-Saharan Africa: a mixed methods analysis. Roberts ST, Mancuso N, Williams K, Nabunya HK, Mposula H, Mugocha C, Mvinjelwa P, Garcia M, Szydlo DW, Soto-Torres L, Ngure K, Hosek S. J Int AIDS Soc; 2023 Nov 06; 26(11):e26189. PubMed ID: 37936551 [Abstract] [Full Text] [Related]
12. Assessing the acceptability of, adherence to and preference for a dual prevention pill (DPP) for HIV and pregnancy prevention compared to oral pre-exposure prophylaxis (PrEP) and oral contraception taken separately: protocols for two randomised, controlled, cross-over studies in South Africa and Zimbabwe. Friedland BA, Mgodi NM, Palanee-Phillips T, Mathur S, Plagianos MG, Bruce IV, Lansiaux M, Murombedzi C, Musara P, Dandadzi A, Reddy K, Ndlovu N, Zulu SK, Shale LR, Zieman B, Haddad LB. BMJ Open; 2024 Mar 12; 14(3):e075381. PubMed ID: 38479746 [Abstract] [Full Text] [Related]
14. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study. Cholo FA, Dada S, Martin CE, Mullick S. J Int AIDS Soc; 2024 May 12; 27(5):e26249. PubMed ID: 38695102 [Abstract] [Full Text] [Related]
15. Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trial. Velloza J, Donnell D, Hosek S, Anderson PL, Chirenje ZM, Mgodi N, Bekker LG, Marzinke MA, Delany-Moretlwe S, Celum C. Lancet HIV; 2022 Oct 12; 9(10):e680-e689. PubMed ID: 36087612 [Abstract] [Full Text] [Related]
16. Exploring user and stakeholder perspectives from South Africa and Uganda to refine microarray patch development for HIV PrEP delivery and as a multipurpose prevention technology. Ismail A, Magni S, Katahoire A, Ayebare F, Siu G, Semitala F, Kyambadde P, Friedland B, Jarrahian C, Kilbourne-Brook M. PLoS One; 2023 Oct 12; 18(8):e0290568. PubMed ID: 37651432 [Abstract] [Full Text] [Related]
20. Uptake of and adherence to oral pre-exposure prophylaxis among adolescent girls and young women at high risk of HIV-infection in Kampala, Uganda: A qualitative study of experiences, facilitators and barriers. Kayesu I, Mayanja Y, Nakirijja C, Machira YW, Price M, Seeley J, Siu G. BMC Womens Health; 2022 Nov 10; 22(1):440. PubMed ID: 36357920 [Abstract] [Full Text] [Related] Page: [Next] [New Search]